Skip to main content
. 2002 Nov 11;99(25):16168–16173. doi: 10.1073/pnas.242600099

Fig 6.

Fig 6.

Immunohistochemical analysis of antigen expression in preinfusion tumor and recurrent postinfusion tumor nodule appearing after MART1-specific T cell therapy. Gp100, tyrosinase, and MART1 expression are seen in the tumor sample preinfusion. Selective loss of MART1 expression is seen in postinfusion tumor cells, demonstrating the outgrowth of antigen-loss tumor variant.